Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
Ray-Coquard, Isabelle; Pautier, Patricia; Pignata, Sandro; Pérol, David; González-Martín, Antonio; Berger, Regina; Fujiwara, Keiichi; Vergote, Ignace; Colombo, Nicoletta; Mäenpää, Johanna; Selle, Frédéric; Sehouli, Jalid; Lorusso, Domenica; Guerra Alía, Eva M; Reinthaller, Alexander; Nagao, Shoji; Lefeuvre-Plesse, Claudia; Canzler, Ulrich; Scambia, Giovanni; Lortholary, Alain; Marmé, Frederik; Combe, Pierre; de Gregorio, Nikolaus; Rodrigues, Manuel; Buderath, Paul; Dubot, Coraline; Burges, Alexander; You, Benoît; Pujade-Lauraine, Eric; Harter, Philipp; for the PAOLA-1 Investigators (2019)
Ray-Coquard, Isabelle
Pautier, Patricia
Pignata, Sandro
Pérol, David
González-Martín, Antonio
Berger, Regina
Fujiwara, Keiichi
Vergote, Ignace
Colombo, Nicoletta
Mäenpää, Johanna
Selle, Frédéric
Sehouli, Jalid
Lorusso, Domenica
Guerra Alía, Eva M
Reinthaller, Alexander
Nagao, Shoji
Lefeuvre-Plesse, Claudia
Canzler, Ulrich
Scambia, Giovanni
Lortholary, Alain
Marmé, Frederik
Combe, Pierre
de Gregorio, Nikolaus
Rodrigues, Manuel
Buderath, Paul
Dubot, Coraline
Burges, Alexander
You, Benoît
Pujade-Lauraine, Eric
Harter, Philipp
for the PAOLA-1 Investigators
2019
New England Journal of Medicine 381 25
2416-2428
Lääketieteen ja terveysteknologian tiedekunta - Faculty of Medicine and Health Technology
This publication is copyrighted. You may download, display and print it for Your own personal use. Commercial use is prohibited.